Ovulation & Hormonal Disorders — Symptoms, Causes & Treatment

Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO. Last updated: June 2026.

Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.

What is anovulation, and why does it prevent pregnancy?

Anovulation — the medical term for a cycle in which no egg is released — means there is nothing available for a sperm to fertilise, so natural conception cannot occur in that cycle. Oligo-ovulation, where ovulation happens only occasionally or unpredictably, has the same practical effect: conception may theoretically be possible, but the fertile window is too uncertain to rely on. Together, anovulation and oligo-ovulation account for a substantial proportion of infertility cases — and because the underlying causes span the hypothalamus, pituitary, ovaries, and other endocrine glands, finding the right cause is the most important first step.

In Hindi and Marathi, irregular or absent ovulation is sometimes described as अनोव्युलेशन (anovulation) — a term your doctor may use during your consultation.

The visible clues that ovulation may be disrupted include:

• Amenorrhoea: periods absent for three or more consecutive months (when not pregnant).
• Oligomenorrhoea: cycles longer than 35 days or fewer than eight per year.
• Highly variable cycles: timing shifts significantly from month to month, making the fertile window unpredictable.

Irregular periods on their own do not always mean there is no ovulation — but they are a reliable signal worth investigating. For the broader picture of menstrual cycle changes, see our menstrual disorders page.

How does the HPO axis control ovulation — and where can it go wrong?

Every ovulatory cycle begins with a pulse of GnRH (gonadotrophin-releasing hormone) from the hypothalamus. GnRH tells the pituitary gland to release FSH (follicle-stimulating hormone) and LH (luteinising hormone). FSH stimulates a follicle in the ovary to mature and produce oestrogen; rising oestrogen triggers a surge of LH, which triggers ovulation — the follicle ruptures and the egg is released. A disruption at any level of this cascade prevents ovulation.

Clinically, ovulatory disorders are grouped by where the disruption occurs:

In addition, disruption can arrive from outside the HPO axis — primarily from the pituitary (excess prolactin), the thyroid gland, or the adrenal/androgen system.

Hypothalamic amenorrhoea — when the brain pauses reproductive signalling

Hypothalamic amenorrhoea (HA) is a WHO Class I disorder in which the hypothalamus reduces or stops its GnRH pulses, silencing the entire downstream cascade. FSH, LH, and oestrogen all fall, and ovulation stops. A blood panel during HA typically looks similar to the hormone picture seen in menopause — low oestrogen, low gonadotrophins — even in a woman in her twenties or thirties. Ovarian structure and AMH are usually normal, which helps distinguish HA from premature ovarian insufficiency.

What causes hypothalamic amenorrhoea?

The hypothalamus is exquisitely sensitive to energy balance. The most common drivers are:

• Energy deficit — the body's calorie intake is insufficient to support both daily function and reproduction. This can occur with restrictive eating, high-intensity or high-volume exercise, or a combination of both. The degree of restriction does not need to be extreme; consistent underfuelling relative to activity is enough.
• Very low body weight or very low body-fat percentage — adipose tissue is a source of oestrogen. When fat stores fall below a threshold, the hormonal substrate for ovulation is insufficient.
• Psychological stress — chronic or severe stress activates the HPA (hypothalamic–pituitary–adrenal) axis, which in turn inhibits GnRH pulsatility. This is a protective evolutionary mechanism, not a character flaw.
• Functional (no identifiable trigger) — in a minority of women, no single cause is clearly identified.

Recognising hypothalamic amenorrhoea

Key features that point toward HA rather than other causes:

• Absent or infrequent periods with a history of significant weight change, intense exercise load, or psychological stress.
• Low or low-normal FSH and LH; low oestradiol.
• Normal prolactin and normal thyroid function (other causes excluded).
• Normal AMH and ovarian follicle appearance on ultrasound (distinguishes from POI).

How is hypothalamic amenorrhoea treated?

The primary treatment is to address the underlying energy or stress imbalance:

• Energy restoration: Increasing caloric intake to meet total energy needs; reducing exercise volume or intensity where appropriate; working with a dietitian experienced in hormonal health.
• Psychological support: Cognitive and psychological approaches that address the stress or psychological contributors.
• Patience with recovery: Ovulation recovery after restoring energy balance can take several months. This is normal; the hypothalamic pulsatile rhythm rebuilds gradually.

For women trying to conceive who have made lifestyle changes but have not yet regained ovulation, ovulation induction using low-dose gonadotrophins can be considered under careful monitoring. Oral agents such as letrozole or clomiphene are generally less effective in WHO Class I anovulation, because the problem lies upstream of the ovary — the ovary itself is functional and capable of responding to adequate hormonal stimulation.

Hyperprolactinaemia — when excess prolactin suppresses the cycle

Prolactin is the pituitary hormone that drives milk production after childbirth. Outside of pregnancy and breastfeeding, prolactin levels should be low. When prolactin is persistently elevated — a condition called hyperprolactinaemia — it suppresses GnRH directly, which reduces FSH and LH and disrupts ovulation. The result is irregular or absent periods, sometimes accompanied by galactorrhoea (spontaneous milk production from the breast outside of pregnancy or breastfeeding), and difficulty conceiving.

What causes raised prolactin?

• Prolactinoma: A benign pituitary adenoma (non-cancerous tumour) that secretes prolactin. This is the most common identifiable structural cause. Most are microadenomas (under 10 mm in diameter). An MRI of the pituitary gland is performed to assess for a prolactinoma when prolactin is persistently elevated.
• Medications: Several medicines commonly raise prolactin — antipsychotics, metoclopramide, domperidone, and some antidepressants. If you are taking any of these and your periods have changed, this connection is worth discussing with your prescribing doctor.
• Hypothyroidism: Underactive thyroid raises TRH (thyrotrophin-releasing hormone), which in turn stimulates prolactin secretion. Treating the thyroid condition normalises prolactin without separate prolactin-specific treatment.
• Physiological variation: Prolactin rises naturally with stress, recent exercise, sleep, breast stimulation, and a carbohydrate-rich meal. A single elevated result must always be confirmed with a fasting, rested, unstressed repeat sample before acting on it.
• Idiopathic: No tumour or medication is identified; elevated prolactin with no structural cause.

How is hyperprolactinaemia treated?

• Prolactinoma: Dopamine agonists — most commonly cabergoline, or bromocriptine — are the first-line treatment. They reduce prolactin secretion, shrink the tumour, and restore ovulation in the majority of cases within weeks to a few months. Results vary by individual.
• Medication-related: Review with the prescribing doctor to explore whether a prolactin-sparing alternative is clinically appropriate.
• Hypothyroidism-related: Correcting the thyroid disorder normalises prolactin.

Once prolactin has returned to normal, many women resume ovulation spontaneously. If ovulation does not resume, ovulation induction can be added.

PCOS — the most common ovulatory disorder

PCOS (polycystic ovary syndrome) is the most common single cause of anovulatory infertility, accounting for the majority of WHO Class II ovulatory disorders. Because PCOS involves specific diagnostic criteria, management approaches, and long-term health considerations, it has a dedicated page on this site. This page focuses on the other hormonal causes of ovulatory disruption.

If PCOS is your concern, please read the PCOS page, which covers Rotterdam criteria diagnosis, androgen excess, insulin resistance, ovulation induction for PCOS, and more.

Premature ovarian insufficiency — when the ovarian reserve is reduced early

Premature ovarian insufficiency (POI) — sometimes called early menopause — occurs when the ovaries cease or significantly reduce their normal function before the age of 40, resulting in low oestrogen and elevated FSH. This is a WHO Class III picture. POI does not always mean complete, permanent ovarian failure — intermittent ovulation can occur — but egg numbers and egg quality are typically reduced, and fertility is significantly affected.

POI is managed differently from other ovulatory disorders. For detail on diminished ovarian reserve and AMH, see our dedicated pages on menopause and early menopause and low AMH.

Thyroid dysfunction — how the thyroid disrupts the reproductive cycle

Thyroid hormones regulate virtually every metabolic process in the body, including the reproductive system. Both an underactive thyroid (hypothyroidism) and an overactive thyroid (hyperthyroidism) can disrupt menstrual cycles and suppress ovulation.

Hypothyroidism (underactive thyroid)

• Overt hypothyroidism (elevated TSH, low free T4) causes irregular or absent periods, can raise prolactin as a secondary effect, and is associated with increased miscarriage risk.
• Subclinical hypothyroidism (elevated TSH with normal free T4): many fertility guidelines recommend a lower TSH treatment threshold for women actively trying to conceive or undergoing IVF than for the general population; your doctor will advise the appropriate target based on current guidance.
• Autoimmune thyroid disease (Hashimoto's): Anti-TPO antibodies indicate autoimmune thyroid inflammation. Some studies have associated positive TPO antibodies with increased miscarriage risk even when TSH and T4 are normal — though the evidence on this continues to evolve.

Treatment with levothyroxine normalises TSH and typically improves cycle regularity and reduces miscarriage risk.

Hyperthyroidism (overactive thyroid)

An overactive thyroid can cause short, infrequent, or absent periods and impairs ovulation. Untreated hyperthyroidism during pregnancy is associated with complications including miscarriage and preterm birth. Treatment — antithyroid medications, radioiodine, or surgery, depending on the clinical situation — normalises thyroid function; fertility generally improves with adequate treatment. Results vary by individual.

Thyroid testing in fertility

TSH is a standard component of every routine fertility blood panel. Free T4 and TPO antibodies are added when TSH is outside the normal range or when autoimmune thyroid disease is suspected. Collaboration with an endocrinologist is appropriate for complex or refractory cases.

Adrenal and androgen disorders — other hormonal causes

Excess androgens (male-type hormones) — from sources other than the ovary — can also suppress ovulation by disrupting the HPO axis. The adrenal glands produce androgens including DHEAS (dehydroepiandrosterone sulphate); elevated DHEAS without the full PCOS picture may indicate an adrenal source of androgen excess, including, rarely, a condition called non-classical congenital adrenal hyperplasia (NCCAH), which is investigated with targeted testing where clinically indicated.

Poorly controlled type 2 diabetes, which is often associated with PCOS but can exist independently, also disrupts hormonal regulation and cycle regularity through insulin resistance and androgen pathways.

These conditions are typically identified through the same blood panel used for the standard fertility assessment and then investigated further with targeted testing where indicated.

How are ovulatory and hormonal disorders diagnosed?

The diagnostic pathway combines hormonal blood tests, ultrasound, and targeted investigations based on the initial picture. Dr. Shweta Agarwal tailors the workup to your symptom history — including your cycle pattern, weight and exercise history, and any associated symptoms such as galactorrhoea or thyroid symptoms.

See our fertility assessment page for the full diagnostic overview.

What are the treatment options for ovulatory and hormonal disorders?

Treatment is cause-specific — correcting the underlying hormonal disruption is the first step, not simply trying to force ovulation while the root problem persists.

• Hypothalamic amenorrhoea: Restore energy balance, moderate exercise, address psychological contributors. Gonadotrophin-based ovulation induction where lifestyle measures alone have not restored ovulation after a reasonable period.
• Hyperprolactinaemia (prolactinoma or idiopathic): Dopamine agonists (cabergoline, bromocriptine) to normalise prolactin; ovulation often resumes spontaneously.
• Medication-induced raised prolactin: Review with the prescribing doctor; consider a prolactin-sparing alternative where appropriate.
• Hypothyroidism: Levothyroxine to normalise TSH before or alongside fertility treatment.
• Hyperthyroidism: Antithyroid treatment in collaboration with endocrinology; fertility treatment deferred until thyroid function is stable.
• PCOS: See the dedicated PCOS page and ovulation induction.
• POI / diminished ovarian reserve: See low AMH and menopause; options discussed individually.
• Adrenal/androgen excess: Targeted medical treatment of the adrenal cause; then ovulation induction if needed.
• Ovulation induction: Once the underlying cause is addressed, or where the cause cannot be fully reversed, ovulation can often be stimulated with oral agents (letrozole, clomiphene) or injectable gonadotrophins, with ultrasound monitoring of follicle development.
• IVF: Recommended when ovulation induction alone has not resulted in pregnancy, when there are additional infertility factors, or when ovarian reserve is significantly reduced. IVF at Aansh is performed with an in-house embryology lab under the care of Senior Clinical Embryologist Aayush Agarwal, Ph.D..

The reassuring message for most ovulatory disorders is that the cause, once identified, can usually be treated — and treatment often restores ovulation without the need for assisted reproduction.

Cost of treatment varies by pathway. 0% EMI financing options (3–24 months) are available. Final cost depends on individual clinical evaluation — see Costs & EMI for current pricing.

When should I seek an evaluation for an ovulatory disorder?

Consider booking a consultation with Dr. Shweta Agarwal if:

• Your periods are consistently absent or fewer than eight per year.
• You have been trying to conceive for 6 months or more without success.
• You have been told your prolactin, TSH, or other hormone levels are outside the normal range.
• You have a history of significant weight change, high-volume exercise, or sustained psychological stress alongside cycle changes.
• You notice spontaneous milk production (galactorrhoea) unrelated to pregnancy or breastfeeding.
• You experience thyroid symptoms — fatigue, cold sensitivity, hair changes, unexplained weight change.
• You have a known diagnosis of PCOS but your cycles remain very irregular.

Early evaluation protects both your fertility options and your long-term hormonal health.